High-Dose-Rate Brachytherapy as Monotherapy for Prostate Cancer
作者： Yasuo Yoshioka , Minako Sumi , Masahiko Oguchi
DOI: 10.1007/978-981-13-0490-3_13
关键词: Radiation treatment planning 、 Dose distribution 、 Radiology 、 Dose escalation 、 Brachytherapy 、 Prostate cancer 、 High-Dose Rate Brachytherapy 、 Clinical evidence 、 Radiation therapy
摘要: High-dose-rate (HDR) brachytherapy as monotherapy for prostate cancer has theoretical advantages in both aspects of radiation physics and biology compared to other radiotherapy modalities. The three-dimensional four-dimensional dose distribution HDR is superb, maximizes the biological escalation. In former part this chapter, techniques implant treatment planning are mentioned, followed by it’s advantages. latter half, clinical evidence overviewed along with its history over 20 years. Since dawning four- nine-fraction regimens, been moving on more hypofractionated regimens. latest two- or single-fraction vigorously discussed.
springer.com
sci-hub.st 参考文章(64)
Yasuo Yoshioka, Osamu Suzuki, Fumiaki Isohashi, Yuji Seo, Hirofumi Okubo, Hiroko Yamaguchi, Michio Oda, Yuki Otani, Iori Sumida, Motohide Uemura, Kazutoshi Fujita, Akira Nagahara, Takeshi Ujike, Atsunari Kawashima, Ken Yoshida, Hideya Yamazaki, Norio Nonomura, Kazuhiko Ogawa, High-Dose-Rate Brachytherapy as Monotherapy for Intermediate- and High-Risk Prostate Cancer: Clinical Results for a Median 8-Year Follow-Up. International Journal of Radiation Oncology Biology Physics. ,vol. 94, pp. 675- 682 ,(2016) , 10.1016/J.IJROBP.2015.05.044
Henrik Hauswald, Mitchell R. Kamrava, Julia M. Fallon, Pin-Chieh Wang, Sang-June Park, Thanh Van, Lalaine Borja, Michael L. Steinberg, D. Jeffrey Demanes, High-Dose-Rate Monotherapy for Localized Prostate Cancer: 10-Year Results International Journal of Radiation Oncology Biology Physics. ,vol. 94, pp. 667- 674 ,(2016) , 10.1016/J.IJROBP.2015.07.2290
Thomas Martin, Dimos Baltas, Ralf Kurek, Sandra Röddiger, Marina Kontova, Georgios Anagnostopoulos, Thomas Dannenberg, Thomas Buhleier, Georgies Skazikis, Ulf Tunn, Nikolaos Zamboglou, 3-D conformal HDR brachytherapy as monotherapy for localized prostate cancer: A pilot study Strahlentherapie Und Onkologie. ,vol. 180, pp. 225- 232 ,(2004) , 10.1007/S00066-004-1215-4
Janusz Skowronek, Low-dose-rate or high-dose-rate brachytherapy in treatment of prostate cancer - between options. Journal of Contemporary Brachytherapy. ,vol. 5, pp. 33- 41 ,(2013) , 10.5114/JCB.2013.34342
Peter Hoskin, Ana Rojas, Peter Ostler, Robert Hughes, Roberto Alonzi, Gerry Lowe, Linda Bryant, High-dose-rate brachytherapy with two or three fractions as monotherapy in the treatment of locally advanced prostate cancer Radiotherapy and Oncology. ,vol. 112, pp. 63- 67 ,(2014) , 10.1016/J.RADONC.2014.06.007
Andrzej Marek Kukiełka, Tomasz Dąbrowski, Tomasz Walasek, Agnieszka Olchawa, Roksana Kudzia, Dorota Dybek, High-dose-rate brachytherapy as a monotherapy for prostate cancer--Single-institution results of the extreme fractionation regimen. Brachytherapy. ,vol. 14, pp. 359- 365 ,(2015) , 10.1016/J.BRACHY.2015.01.004
I-Chow Joe Hsu, Yoshiya Yamada, Dean G. Assimos, Anthony V. D'Amico, Brian J. Davis, Steven J. Frank, Alexander R. Gottschalk, Gary S. Gustafson, Patrick W. McLaughlin, Paul L. Nguyen, Seth A. Rosenthal, Al V. Taira, Neha Vapiwala, Gregory Merrick, ACR Appropriateness Criteria high-dose-rate brachytherapy for prostate cancer Brachytherapy. ,vol. 13, pp. 27- 31 ,(2014) , 10.1016/J.BRACHY.2013.11.007
Jian Z. Wang, M. Guerrero, X.Allen Li, How low is the α/β ratio for prostate cancer? International Journal of Radiation Oncology Biology Physics. ,vol. 55, pp. 194- 203 ,(2003) , 10.1016/S0360-3016(02)03828-2
Eduard Mullokandov, Glen Gejerman, Analysis of serial CT scans to assess template and catheter movement in prostate HDR brachytherapy. International Journal of Radiation Oncology Biology Physics. ,vol. 58, pp. 1063- 1071 ,(2004) , 10.1016/J.IJROBP.2003.08.020
Raymond Miralbell, Stephen A. Roberts, Eduardo Zubizarreta, Jolyon H. Hendry, Dose-Fractionation Sensitivity of Prostate Cancer Deduced From Radiotherapy Outcomes of 5,969 Patients in Seven International Institutional Datasets: α/β = 1.4 (0.9–2.2) Gy International Journal of Radiation Oncology Biology Physics. ,vol. 82, ,(2012) , 10.1016/J.IJROBP.2010.10.075